Latest news
Can Vitrafy Life Sciences (ASX:VFY) Turn Healthcare Innovation Into Commercial Growth? - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 00:30:00 GMTVFY:ASX Announcement - FY26 Appendix 4E and Annual Report - 04 Aug 2026 - Market IndexMarket Index · Tue, 04 Aug 2026 11:38:07 GMTAussie biotechs eye $100 billion US anti germ warfare bonanza - The Daily TelegraphThe Daily Telegraph · Tue, 04 Aug 2026 08:03:02 GMTVitrafy Life Sciences Ltd (ASX:VFY) (FY 2026) Earnings Call Highlights: 94. ... - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 07:00:25 GMTVitrafy Life Sciences Reports 80% Revenue Rise and Halved Net Loss in FY2026 Preliminary Final Results - kalkine.com.aukalkine.com.au · Tue, 04 Aug 2026 03:54:05 GMTVitrafy Life Sciences Unveils FY2026 Annual Results Presentation Highlighting Biologics Infrastructure Development - Kalkine MediaKalkine Media · Tue, 04 Aug 2026 03:54:05 GMTVitrafy Life Sciences Lodges Appendix 4G Corporate Governance Key to Disclosures for FY2026 - kalkine.com.aukalkine.com.au · Tue, 04 Aug 2026 03:54:05 GMTVitrafy Life Sciences Submits Appendix 4G Confirming Corporate Governance Compliance for FY2026 - Kalkine MediaKalkine Media · Tue, 04 Aug 2026 03:54:05 GMT